Introduction
Woodchuck hepatitis virus (WHV) is a member of the genus Orthohepadnavirus of the family Hepadnaviridae, a group of enveloped viruses with a circular, partially double-stranded DNA genome of about 3 kb. Similar to the human hepatitis B virus (HBV), the prototype virus of this group, WHV inflicts acute and chronic hepatitis which may lead to development of hepatocellular carcinoma. Members of this virus family display a narrow host range and tropism to a comparable spectrum of organs. With respect to tissue specificity, molecular evidence of HBV replication has been found both in the liver and lymphatic system (Colucci et al., 198~; Laure et aJ., 1985;  Mason et a]., I992; Michalak eta]., 1994 a; Noonan eta[., 1986; Pasquinelli et al., I990) . Similarly, WHV DNA and viral RNA Author for correspondence: Tomasz transcripts have been identified in the woodchuck liver, peripheral blood mononuclear cells (PBMC) and lymphoid organs (Chemin et al., I992; Korba e~ a]., 1987 Korba e~ a]., , 1988 Michalak et aI., 1994b; Ogston et aI., I989; Pardoe & Michalak, 1995) .
The virions of mammalian hepadnaviruses contain an icosahedral nucleocapsid composed of multiple copies of the core protein and an envelope formed by three related surface proteins embedded in host-derived lipid. The envelope proteins not only assemble into the virion shell but they also form subviral spherical and filamentous particles 20-25 nm in diameter, carrying the surface antigen reactivity (HBsAg and WHsAg for HBV and WHV, respectively), which circulate in abundant quantities in the blood during viraemia. These envelope proteins are encoded within a single viral gene divided by in-flame initiation codons into S, preS2 and preS1 regions. Translation products of these regions, named major or small, middle and large protein, while differing in their Nterminal amino acid sequences share the same C-terminal portion. Analysis of the hydrophilicity and antigenicity profiles implies that the amino acid sequence of the preS1 envelope ~3~ :i domain has the most peripheral location within the virion particle (Heerman & Gerlich, 1991 ; Schaeffer ef at., 1986) . This in turn suggests that that domain could be spatially predisposed to carry the site involved in recognition of a cellular receptor.
The cell receptor-binding site on the WHV envelope remains unidentified. For HBV, the results of numerous studies analysing the interactions between subviral envelope particles, virions or synthetic peptides and various cell lines or human liver cell membranes suggest that the crucial HBV cell attachment site is located within the 22 residue stretch encompassing amino acids 21-47 of the preS1 domain (Dash et a[., I992; Neurath et aI., 1986; Petit eta[., 1992; Pontisso et al., 1989) . This HBV binding site is not strictly human hepatocyte specific, since it recognizes non-hepatic cells of both human and non-human origin, including human peripheral blood B lymphocytes and haematopoietic cell lines of the B cell lineage (Neurath eta]., 1990) . To the present time, several cell constituents have been proposed to play a role in the initial binding of HBV to human hepatocytes or lymphocytes (Budkowska et al., 1993; Franco et al., I992; Neurath et al., 1992; Pontisso et al., 1989 Pontisso et al., , 1992 Treichel et aI., 1994) . The significance of these postulated multiple receptor systems for virus entry and the initiation of infection remains uncertain, mainly due to the lack of an efficient cell system capable of supporting virus propagation after in vitro exposure to virions.
Nevertheless, interpreting this apparent virus infidelity to the cell surface receptor in the context of the highly restricted virus host and cell specificity, it is necessary to consider that viral tropism could be determined by cell-specific interactions mediated by sequences which become operational due to a structural change in viral envelope occurring following virus entry to host targeted organ or subsequent to the initial virion-cell contact.
M e t h o d s
• WHV and subviral envelope particles. Virions were prepared by pelleting plasma from a chronic WHV carrier through 30% sucrose (w/v) at 200000 ,g for 30 h and washing the virion-enriched pellet twice by ultracentrifugation. Subviral envelope particles (WHsAg) were isolated from a pool of WHsAg-positive sera from woodchucks chronically infected with WHV as described (Michalak & Churchill, 1988) . The polypeptide composition of the WHV and WHsAg particles was determined by western blotting with polyvalent rabbit antibody to WHsAg (Rb anti-WHs) (Michalak &Lin, 1994) , Analysis showed that virions contained all molecular species typical for both gtycosylated and non-glycosylated forms of envelope proteins, while native subvira[ WHsAg particles displayed the large 39 kDa and 42 kDa, middle 36 kDa and major 23 kDa and 26 kDa envelope proteins, but not the middle 33 kDa polypeptide (Michalak &Lin, 1994) . Ultrastructural examination of WHV particles showed typical 43 nm diameter virions, some subviral WHsAg tubular forms and small amounts of 22 nm spherical particles, whereas the WHsAg preparation contained spherical 22 nm diameter forms and a limited number of tubules.
• Enzyme and chemical treatment of natural WHV envelope. • S y n t h e t i c p e p t i d e s . Peptides comprising residues 1-25 at the N terminus of the large WHV envelope protein were chemically synthesized at more than 85 % purity using the Fmoc strategy. This 25 amino acid fragment was originally selected for investigation from the sequence encoded by the WHV preS1 and preS2 genomic regions based on parameters indicative of residues likely to be accessible at the protein surface (PC/Gent; Intelligenetics). The predictive algorithms suggested that the tetrabasic NPDK sequence at positions 10-13 is the site with highest probability for B-turn occurrence in the whole preS-encoded sequence ( Fig. 1) , it also corresponds with a minor peak on a hydrophilicity profile of the sequence. Oligopeptides LPI (1-25), JPI 83f
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(1-13) and MP3 (9-14), containing the tetrabasic motif, and additional short partially overlapping peptides MP1 (1-7), MP2 (5-9) and MP4 (13-17) were prepared to achieve fine mapping of the predicted site ( Fig.  1 ). Synthetic peptides comprising sequences unrelated to the WHV proteins, such as HBV adw preSI 23-32, 32-49 and 92-107 (kindly provided by C. R. Howard, Department of Pathology and Infectious Diseases, Royal Veterinary College, London, UK), HBV ayzv preS1 120-143 and human immunodeficiency virus (HIV) gp120 254-274 (both purchased from Sigma), were used in control experiments. Peptides LP1 (1-25) and JP1 (1-13) were reconstituted in 10 raM-acetic acid at pH 3'6 and then adjusted to pH 7"4 with PBS, whereas remaining peptides were directly solubilized in PBS prior to use. When needed, peptides were labelled with Nal=SI (200 ,Ci per labelling reaction; activity 10 llCi/l~l; Amersham) by the IODO-GEN method (Pierce) (Jin et al., 1994) . Specific activity of radiolabelled peptides ranged between 0"5-2'0 x 10 ~ c.p.m./~g.
• Antibodies. Antisera against LP1 (I-25) peptide (anti-LP1) were produced in two rabbits by intradermal injection at multiple sites with 0"8 mg of the peptide emulsified in complete Freund's adjuvant. Four and 8 weeks later, each animal was boosted with an intramuscular injection of 0"5 mg of LP1 (1-25) with incomplete Freund's adjuvant. The antisera obtained approximately 5 months after the last booster injection, showing a titre of 1:4000 against LP1 (1-25) by the peptide-specific enzyme-linked immunosorbent assay (ELISA), were used in this study. Rabbit antibodies to natural, serum-derived subviral WHsAg particles (Rb anti-WHs), recognizing all constituent polypeptides of the WHV envelope, were produced and characterized previously (Michalak & Churchill, 1988; Michalak & Lin, 1994) .
• Sera. Sera from woodchucks experimentally infected with WHV which developed acute WHV hepatitis, confirmed by serology and histological assessment of liver biopsies (MichaIak & Lin, 1994) , that had recovered from the infection, as judged by the clearance of serum WHsAg and the appearance of antibodies to WHsAg (anti-WHs), were assayed for antibody directed against the N-terminal preS1 sequence (anti-WHV CBS1) using peptide ELISA as described below. Anti-WHs and antibody to WHV core antigen (anti-WHc) were detected by specific ELISA using purified serum WHsAg or liver-derived WHV core particles as substrate. WHsAg was identified by a cross-reactive radioimmunoassay for HBsAg (Ausria II, Abbott) with a relative sensitivity for the detection of purified WHsAg of 3"25 ng protein/ml. Serum WHV DNA was evaluated by a polymerase chain reaction (PCR) using primers specific for the WHV core gene (Pardoe & Michalak, 1995) (approximate sensitivity for detection of direct and nested amplification products on ethidium bromide-stained agarose gels, 103 and 102 genome equivalents/ml, respectively).
• Antibody assays. A solid-phase ELISA was developed to determine anti-LP1 and anti-WHs reactivities in the raised rabbit antisera and antibodies against virions and subviral WHsAg particles and against the WHV preS1 and WHV unrelated peptides in the sera of woodchucks infected with WHV. Microtitre plates (96-well; INC Biochemicals) were coated with 200 ng of a synthetic peptide or with 200 ng protein/well of natural virions or with intact or treated subviral envelope particles. The plates were washed and non-specific-binding sites were blocked with PBS containing I0% fetal calf serum (FCS; Flow Laboratories) and 0'05% Tween 20 for 4 h at 4 °C or for 2 h at 22 °C. The plates were then incubated with serial twofold dilutions of tested rabbit or woodchuck sera. Following washing, the wells were incubated with afffinity-purified goat anti-rabbit Ig [heavy and light chains (H + L)] conjugated with horseradish peroxidase (Bio-Rad) or with rabbit anti-woodchuck IgG (Michalak eta[., 1990) and then with peroxidase-labelled goat anti-rabbit Ig (H + L). The reaction was developed using a peroxidase EIA substrate kit (Bio-Rad). The antibody dilutions showing an A450 greater than that given by a i:I0 dilution of preimmune rabbit sera or sera obtained from woodchucks before inoculation with WHV were considered positive. All determinations were done at least in duplicate.
To determine the specificity of anti-LP1 antibody toward the WHV envelope modified by protease treatment, a competitive ELISA was developed. Microtitre plates coated with subviral WHsAg particles digested with 5. griseus protease immobilized on beaded agarose for 5 rain at 22 °C (conditions as those described above) were incubated with anti-LP1 at a I : 500 dilution for 2 h at 37 °C in the presence of increasing concentrations (100 ng-6 ,g) of synthetic peptides homologous to the N-terminal WHV preS1 residues 1-25. After washing with PBS/O'05 % Tween 20, the reaction was visualized as described for the antibody ELISA. The results were expressed as percentage of inhibition calculated using the following formula: percentage inhibition = (negative controltest sample)/(negative control -positive control) x 100, The A4~ o values given in the absence of competing peptide were taken as negative controls, whereas background readings in the presence of PBS instead of anti~LP1 were used as positive controls.
• Cells. PBMC were isolated on Histopaque 1119 gradients (Sigma) from blood of healthy woodchucks, rats and a human (Michalak et al., 1995) . Cells were depleted of residual erythrocytes by lysis with 0"83% NHdCL and washed three times in Hanks' balanced salt solution (HBSS). In some instances, PBMC at 1 x 106-2 x 106/ml were cultured for 3 days in RPMI 1640 medium with 10% FCS, 2 mM-L-glutamine, 0"05% 2mercaptoethanol, penicillin (100 U/rnl) and streptomycin (100 ,g/roll supplemented with 5 ,g/ml Concanavalin A (ConA; Sigma) or 10 i~g/ml lipopolysaccharide (LPS; Sigma). The mitogen-stimulated PBMC were extensively washed in HBSS and directly used in experiments. Spleen lymphoid cells (splenocytes; mostly lymphocytes) were prepared from normal woodchucks and rats as described (Michalak et al., I995) . After lysis of residual erythrocytes and washing, the isolated cells were incubated on plastic for 1 h at 37 °C under 5% CO 2 atmosphere to remove macrophages. Essentially the same procedure was employed to isolate lymphoid cells from woodchuck femoral bone marrow. Hepatocytes were isolated by two-step collagenase peffusion from normal woodchuck liver under conditions previously described in detail (Michalak & Churchill, 1988; Michalak & Lin, 1994) .
• Dot-blot assay. Samples (100 ~l) derived from hepatocytes and lymphoid cells or mitogen-stimulated PBMC were immobilized at the desired protein concentration onto nitrocellulose. The blots (8 x 12 cm) were preincubated in PBS containing 10% FCS and 0'05 % Tween 20 for 2 h at 22 °C to prevent non-specific binding, washed with PBS/O'05 % Tween 20 and incubated with approximately 2 x 106 c.p.m, of z~sIlabelled peptides (approximately 1 I~g) in 10 ml of 1% FCS and 0"05 % Tween 20 in PBS for 2 h at 22 °C or overnight at 4 °C. In some experiments, the individual dots with immobilized cellular proteins were cut out, incubated with a blocking solution, washed and exposed to increasing amounts of radiotabelled peptides (approximately 0-1-3"Z ,g/dot). Alternatively, the dots were preincubated with unlabelled peptide (approximately 50 ,g/dot) in a 100 ,I reaction volume for 2 h at 22 °C and then supplemented with 100 ,l of z26I-peptide (approximately 1 ,g/dot) in PBS and incubated for an additional 30 rain at 22 °C. After washing with PBS/0"05% Tween 20, the bound radioactivity was determined in a gammacounter.
• Inhibition I=LISA. In addition to a direct dot-blot assay, an inhibition ELISA for the detection of a cellular moiety capable of reaction with the WHV preS1 cell-binding site (WHV CBS1) was developed. To test this activity, soluble extracts were prepared from woodchuck, rat or human IP: 54.70.40.11
On: Thu, 13 Dec 2018 03:31:19 i!{{{{{{{{{!{iiiii!ii¥ia iiiiig a{i6: !ii!iiiiiiiiiii}{ii PBMC or woodchuck and rat hepatocytes and splenocytes by intermittent sonication on ice of I x 106 cells/sample in 400 I~1 of PBS with 2 mM-PMSF and 1 mM-N-ethylmaleimide as protease inhibitors and subsequent separation of insoluble debris at 13600g for 10 s. A comparable method was employed to obtain a soluble extract from woodchuck kidney homogenate. The assay used was based on inhibition of the binding of anti-LP1 antibody to peptides or protease-treated subviral WHsAg particles immobilized on microtitre plates as described for antibody ELISA. The peptide-or WHsAg-coated wells were incubated for 3 h at ambient temperature with 50 p,g protein/well of cell extracts, washed with PBS/0"05 % Tween 20 and then incubated with anti-LP1 or PBS as control. The reactions were developed and detected at A4~ 0 as described for antibody ELISA. The results were expressed as percentage inhibition calculated according to the formula for the antibody ELISA, where the A460 values obtained from reactions of anti-LP1 with peptides or protease-treated subviral WHV envelope particles in the absence of tissue or cell extracts and from background reading in the absence of anti-LPI were used as negative and positive controls, respectively.
Results

Anti-LP1 preferentially identifies WHV preSl 10-1 3 epitope
In peptide ELISA, antibody raised against LP1 (1-25) reacted with all synthetic peptides containing the W H V preS1 NPDK motif that were tested (Fig. 2) . In fact, the antibody displayed a 16-fold greater reactivity toward the hexapeptide MP3 (9-14), containing the NPDK sequence and a single amino acid flanking each side, than against LP1 (1-25) used for immunization (titres 1:64000 and 1:4000, respectively) or against JP1 (1-13)and MP1 (1-7)(titres 1:8000 and 1:4000, respectively). The antibody did not react with peptides homologous to residues 5-9 and 13-17 of the N-terminal W H V preSi sequence. Also, anti-LP1 did not recognize W H V unrelated peptides, except a relatively weak reaction with a peptide homologous to residues from 23-32 of the HBV preS1 domain (titre 1 : 160), which encompasses the W H V compatible NPD sequence at the position 29-31 (Fig. 2) . These results indicate that the site of the W H V preS1 domain bearing amino acids 10-13 most likely constitutes a serologically dominant epitope of the virus preS1 domain. In contrast to anti-LP1, Rb anti-WHs raised against native subviral W H s A g particles recognized all the W H V preS1 peptides tested, except MP4 (13-17) (data not shown).
Anti-LPl recognizes proteolytically modified but not natural WHV envelope
Anti-LP1 failed to bind to purified natural W H V virions and subviral envelope particles ( Fig. 2 c and Table 1 ), indicating that the epitope recognized by the antipeptide antibody is not accessible on the surface of unmodified virus envelope. Guided by this finding, purified subviral W H s A g particles were treated with different proteolytic enzymes, a detergent or at various pH conditions in an attempt to expose the anti-LP1 reactive epitope. As shown in Table 1 , mild digestion of W H s A g particles with protease, trypsin or ~-chymotrypsin elicited anti- protease-treated (5 min, 22 °C) natural subviral WHsAg particles is shown for comparison. Two-fold antiserum dilutions starting at 1:20 were reacted with peptides or viral preparations in ELISA. Antiserum dilutions (presented in titre reciprocal values) giving A45 o readings greater than that of preimmune rabbit serum at a 1 : 10 dilution incubated with a given synthetic peptide or WHV preparation were regarded as positive. Table 1 . Effect of enzymes, detergent and pH t r e a t m e n t on r e c o g n i t i o n of natural WHV e n v e l o p e by anti-LP1 antibody Results were obtained by ELISA using serial twofold dilutions of rabbit anti-LPl antibody starting at I:20. The last antibody dilution giving A450 value greater than that of preimmune rabbit serum at a dilution 1 : 10 was regarded as anti-LP1 titre for a given WHV envelope particle substrate. LP1 binding (titres from 1:160 to 1:640). In contrast, prolonged digestion with protease, mild treatment with V8 protease and NP40 or incubation at pH greater than 2 did not affect WHV envelope recognition by anti-LPI (titres below 1 : 20). Further, exposure of subviral envelope particles to pH 2 resulted in relatively weak, although evident, binding of the antibody (titre 1:80) (Table 1) .
Binding (antibody
To exclude the possibility that anti-LP1 recognizes nonspecific binding sites created on the WHV envelope due to proteolytic modification, competitive ELISA of anti-LP1 binding to subviral WHsAg particles subjected to limited protease treatment was performed using peptides homologous to the N-terminal fragment of the WHV preS1 sequence as competitors. As shown in Fig. 3, both LP1 (1-25) and MP3 (9-14) were able to compete in a dose-dependent manner with anti-LP1 and inhibited antibody binding by more than 90%, whereas JP1 (1-13) blocked the binding by approximately 80 %. This effect was highly specific for peptides containing the NPDK sequence because inhibition of the anti-LP1 binding was marginal in the presence of MP2 (5-9) (about 10 %), absent in the presence of MP4 (13-I7) (less than 5 %), and it did not exceed 60 % when MP1 (1-7) peptide was used as a competitor (Fig. 3) . These data demonstrated that natural WHV envelope is not recognized by our anti-LP1 antibody and confirmed that the antibody is strictly directed against the N-terminal fragment of the large WHV envelope protein, in particular, against a determinant containing residues 10-13. In addition, the results revealed that the site with the NPDK sequence becomes accessible for anti-LP] recognition after proteolytic or, to a lesser extent, low pH-dependent change in WHV envelope structure.
Natural antibodies to the N-terminal WHV preS1 sequence
To determine whether a modification of WHV envelope similar to that activated by proteoIytic cleavage has a counterpart in vivo, sera from woodchucks with experimentally induced WHV hepatitis were assayed for antibodies to the virus site containing amino acids 10-I3 (also called anti-WHV CBS1) by a peptide ELISA. In a preliminary experiment, testing sera from several woodchucks convalescing from acute WHV hepatitis which had developed anti-WHs (i.e., antibody reactive with natural WHV envelope) it was established that all anti-WHs-positive sera were capable of recognizing the peptides encompassing the NPDK motif and that the overall spectrum of their antipeptide specificity was comparable to that found for anti-LP1 (see Fig. 2 ). Thus, the natural woodchuck antibody preferentially reacted with MP3 (9-14) (titres usually above I : 2560), to a lesser extent with JP1 (I-I3) and LP1 (1-25) peptides (titres equal to or below 1:1280), relatively weakly recognized MP1 (1-7) (titres equal to or below 1:320) and did not react with MP2 (5-9) and MP4 (13-17) (titres below 1:20).
To determine whether natural antibody to the site bearing amino acids 10-13 (anti-WHV CBS1) occurs independently of anti-WHs and to assess the time flame of its generation in relation to WHV inoculation and the appearance of other serological markers of WHV infection, sequential serum samples collected from woodchucks after virus administration but prior to anti-WHs appearance were tested using ELISA microplates coated with MP3 (9-14) peptide. As shown in Fig.  4 , the animals examined became serum WHsAg reactive between 20 and 55 days (mean+sD, 34"3+18"3) after intravenous WHV injection, cleared the antigen at day 55 to 111 (mean+sD, 78"3+_29"1), and developed anti-WHs between 48 and 118 days post-inoculation (mean -t-SD, 83 + 35). Beginning at day 34 to 62 the animals became anti-WHc reactive (mean q-SD, 45"6-t-14"6) and remained antibody positive until the end of follow-up. In all three animals tested, antibody to the WHV CBS1 appeared at day 20 postinoculation (titres 1:80 to 1:160) and its titres displayed a progressive rise reaching values between 1:320 to 1:1280 at the time of the anti-WHs appearance (Fig. 4) . The detection of WHV DNA preceded the appearance of anti-WHV CBS1 in Wc.1 and Wc.2, whereas the virus genome and the antibody were concomitantly detectable in Wc.3 (mean q-SD, 13"3 -t-5"8). Preinoculation sera from the animals were entirely non-reactive with MP3 (9-14) and with other peptides used in the study. The above data demonstrated that generation of natural anti-iiiiiiiiiii!i!iJi!i!ii~!iii!{~i{~iii~iiiiii!ii!iii31iii WHV CBS1 antibody precedes the appearance of anti-WHs, anti-WHc and WHsAg, indicating that the antibody in fact represents the earliest immunodetectable indicator of WHV infection.
Specificity and kinetics of cellular binding mediated by the N-terminal WHV preS1 sequence
In preliminary experiments, probing by a dot-blot assay of extracts prepared from organs of several woodchucks, a human and mice, it was established that the radiolabelled JP1 (1-13) peptide binds to woodchuck hepatic and splenic tissues, but did not interact to any extent with woodchuck kidney, pancreas, skeletal muscle or with host non-specific tissue substrate. It was also observed that isolated woodchuck hepatocytes and lymphoid cells from spleen and bone marrow bound from 5-to 10-fold greater amounts of the peptides containing the WHV preS1 NPDK sequence than the respective organ homogenate, indicating that isolation of cells led to enrichment of a cellular substance (Michalak et al., 1991) . The interaction between synthetic N-terminal preS1 sequences containing the I0-13 epitope and woodchuck whole hepatocyte and splenocyte substrates showed monophasic saturable binding kinetics when dots containing constant amounts of cell protein (approximately I pg/dot) were incubated with increasing concentrations of 125I-labelled JP1 (1-13), as is shown for woodchuck splenocytes in Fig. 5 . The specificity of the cellular binding was confirmed in competition experiments where 12SI-labelled JP1 (1-13) attachment was almost completely inhibited (more than 90%) after preincubation of the dots with an excess of unlabelled JP1 (1-13) or MP3 (9-14) peptide (approximately 50 ~g/dot) (Fig. 5) . On the contrary, the I~I-JPI (1-13) binding was not affected when the same amounts of unlabelled MP2 (5-9) and MP4 (i3-17) or WHV-unrelated peptides, either HBV preS1 (120-I43) or 6 . Woodchuck cell-specific inhibition of the anti-LP1 antibody binding to protease-modified WHV envelope and synthetic LP1 (1-25) and MP3 (9-13) peptides carrying WHV NPDK cell recognition motif. WHV envelope particles treated with protease for 5 rain at 22 °C or LP1 (1-25) and MP3 (9-13) immobilized on microtitre ELISA plates were preincubated with extracts (50 I~g protein/well) from woodchuck (We) and rat (Rt) hepatocytes, splenocytes and resting PBMC or from human (Hu) resting PBMC, and then washed and probed with anti-LP1. The results were expressed as a percentage inhibition calculated according to the formula presented in Methods and are presented as the average of two determinations. HIV gp120 (254-274), were used for preincubation (data not shown). When the binding data presented in Fig. 5 were replotted in the form of a Scatchard plot (Fig. 5, inset) , it was found that the interaction was mediated by a single class of saturable binding sites. Further, when constant amounts of 12sI-JP1 (1-13) were incubated for different time periods with constant amounts of proteins from woodchuck hepatocyte and splenocyte homogenate, the peptide binding was saturable over incubation time, achieving its maximum in approximately 30 rain (data not shown). Examination of the ability of a variety of tissue and cell extracts to inhibit anti-LP1 binding to protease-modified WHV envelope and to peptides with the NPDK motif in an inhibitory ELISA showed that while the antipeptide antibody reaction with both subviral WHsAg particles treated with protease, LP1 (1-25) and MP3 (9-14), was significantly inhibited by a moiety present in both woodchuck hepatocytes, splenocytes and PBMC (inhibition above 75%), homogenates of woodchuck kidney or rat hepatocytes and splenocytes or rat PBMC extract did not affect the binding (inhibition less than 10%)( Fig. 6) . A similar pattern of the cell substrate specificity was observed when JPI (1-i3) peptide was tested (data not shown). It is worth noting that a soluble fraction from human PBMC reduced the anti-LP1 binding by up to 40% (Fig. 6) . In a complementary control experiment, binding of Rb anti-WHs to the protease-modified envelope particles was not influenced by preincubation with the same tissue or cell substrates (data not shown). Overall, these findings provided consistent evidence indicating that the N-terminal fragment of the large WHV envelope protein contains a host-and cell type-specific binding site, which interacts with a constituent occurring in the woodchuck hepatocyte and lymphoid cells in a manner typical for the specific ligand-receptor binding and that the NPDK sequence plays a critical role in the WHV CBS1 activity.
WHV CBS1 preferentially recognizes host lymphoid cells
Woodchuck lymphoid cells, either PBMC or lymphocytes from spleen and bone marrow, displayed significantly greater capacity for binding of peptides containing the WHV NPDK motif than the woodchuck hepatocytes. Thus, analysis of the LP1 (1-25), JP1 (I-13) or MP3 (9-t4) binding rates to serial twofold dilutions of cellular proteins showed that woodchuck PBMC expressed approximately i000-fold greater capacity for binding of those peptides than woodchuck hepatocytes, as is shown for the MP3 (9-14) binding in Fig. 7 . Furthermore, stimulation of woodchuck PBMC to blast formation and cell division by culture in medium supplemented with ConA or LPS gave a further 2-to 4-fold increase in the attachment rates of the peptides bearing the NPDK motif (Fig. 7) . Again, peptide binding to woodchuck lymphoid cells displayed high host specificity, since resting or mitogen-stimulated rat PBMC were entirely deprived of that binding ability, whereas mitogen-stimulated human PBMC, but not resting cells, reacted at levels approximately 500-fold lower than those for the woodchuck PBMC (Fig. 7) . In control experiments, there was no binding seen between MP2 (5-9) and MP4 (I3-17) or WHV unrelated peptides and cellular substrates mentioned above, except a weak reaction between HIV gp120 and human resting and mitogen-stimulated PBMC (data not shown). Taken together, these findings clearly showed that woodchuck lymphoid ceils express a considerably greater capability to bind the WHV CBS1 sequence than host hepatocytes and that their stimulation with a mitogen further increases this ability.
Discussion
A detailed analysis of the specificity of anti-LP1 antibody elicited against the synthetic sequence mimicking the extreme N-terminal portion of the large WHV envelope protein and the results of peptide binding and competition experiments showed that WHV preS1 determinant bearing amino acids 10-13 recognizes in a host-and cell type-restricted manner cells naturally targeted by the virus, although the site is not directly exposed on the surface of infectious virions or free envelope particles. To some extent a seemingly comparable observation has been previously reported, namely that the in vitro translation preSl-specific product of 43 kDa but not natural envelope of WHV-related ground squirrel hepatitis virus was recognized by an antibody raised against a peptide bearing the extreme N-terminal 13 amino acids of the virus preSI domain (Persing et aI., I986) . It was conceivable that the failure of this antipeptide antibody to react with the native WHV preSI domain could be due to conformation rather than an under-representation of the large proteins in the viral envelope in vivo. Indeed, mild treatment of the WHV envelope with proteases, including serine proteases such as trypsin and ~-chymotrypsin, induced the site-specific anti-LP1 binding, suggesting that proteolytic cleavage is essential for presentation of the determinant containing the NDPK motif on the natural virus particle. The site also became accessible for antibody recognition after exposure of viral envelope to acidic pH, although pH-dependent modulation alone appeared to be less effective in the activation of the site than proteolysis. In contrast, treatment of the viral envelope with serine-type V8 protease, which cleaves at glutamic and aspartic acids, and NP40 did not induce exposure of the determinant, suggesting that cleavage at a particular site is required for its activation and that burying of the determinant within the viral envelope by lipids is unlikely. Our finding that the natural envelope does not express the site bearing NPDK motif at the surface unless subjected to proteolysis and the fact that this site specifically recognizes host cells known to be permissive for WHV infection in vivo emphasizes the possibility that cleavage activation could be crucial for identification of the target cells by the virus. These results also may suggest that this process is controlled by a cellular protease, either secreted by virussusceptible organs or occurring within the endosomes of permissive cells. This concept is consistent with the idea derived from studies on many other enveloped viruses, which postulates that proteolytic cleavage by organ-or cell typespecific endoproteases, often termed trypsin-like enzymes, or a low pH-dependent change of virus envelope proteins is often essential for induction of virus fusion and host ceil ent:ry and consequently for determination of virus cell tropism and pathogenicity (Gotoh et al., 1990; Hallenberger et al., i992; Klenk & Garten, i994) . Similarly, it has also been postulated that the protease or acid pH-dependent activation of the putative fusion sequence located at the N terminus of the HBV S envelope domain is required for in vitro HBV uptake into HepGfi cells (Gerlich et al., i993) .
The strict specificity of anti-LP1 antibody against the extreme N-terminal fragment of the large envelope protein and occurrence of natural antibodies with similar specificity in woodchucks after WHV infection strongly suggested that amino acids I0-13 of the postulated WHV CBS1 also constitute the serologically immunodominant epitope of the WHV preS1 domain. From these findings we can infer that masking of the WHV cell-binding site could be imperative for protection of the site from antibody surveillance and blocking. Since, as we have shown, anti-WHV CBS1 antibodies are generated from the earliest stages of WHV infection, concealing of the ceil recognition site could also be important in allowing virus to spread throughout the host and persist. Furthermore, the appearance of anti-WHV CBS1 preceded the detection of other immunovirologicai markers typically accompanying active or resolved WHV infection, including the appearance of anti-WHs. This indicates that an immunological response against the WHV CBSI was, at least in part, generated independently from a response that induced anti-WHs antibody capable of reacting with epitopes of unmodified WHV envelope. Taking into consideration the natural order in the appearance of viral serological markers in the course of WHV and HBV infections, where antibodies against native virus envelope (i.e., anti-WHs or anti-HBs) are identifiable after clearance of WHsAg or HBsAg from serum and where circulating anti-core antibodies appear usually after detection of viral surface antigens, it is unlikely that the observed early occurrence of the anti-WHV CBS1 response in comparison to those of anti-WHs and anti-WHc could be due to a difference in the sensitivity of the assays used. Identification of anti-WHV CBS1 shortly after or at the time of detection of WHV genome supports the notion that the anti-WHV CBS1 antibody constitutes the earliest serological indicator of WHV invasion in the woodchuck system. Our experiments demonstrated, by various techniques, that the N-terminal fragment of the WHV large envelope protein carries a determinant capable of recognizing woodchuck lymphoid cells and hepatocytes in a highly host-and cell typespecific manner. The binding displayed monophasic, dose-and time-dependent saturable kinetics and was competitively inhibited by excess unlabelled peptides homologous to the WHV preS1 sequence containing the NPDK sequence but not by unrelated viral peptides. Hence, by showing these various characteristics, the binding satisfied the main criteria for receptor-mediated ligand interactions, such as ligand and substrate specificity, saturability and competition, In addition, these findings were consistent with the results from another set of our experiments showing that the anti-LP1 binding to synthetic peptides bearing the WHV NPDK sequence and, more importantly, to protease-treated natural WHV envelope was inhibited by substrates released from woodchuck hepatocytes and lymphoid cells but not by those derived from cells of another species or other woodchuck organs. Interestingly, woodchuck lymphoid ceils, either PBMC or derived from lymphatic organs, demonstrated a significantly greater (approximately 1000-fold) capacity for binding of the WHV CBS1 sequence than the host hepatocytes. If the extent of the observed interactions reflects the natural predisposition of WHV for host cells, these data may suggest that lymphoid cells provide more favourable targets than hepatocytes for virus attack. From the fact that stimulation of normal woodchuck PBMC to cell division and blastoid formation by mitogens led to enhancement of the binding of the WHV CBS1 sequence, it could also be assumed that dedifferentiated or immature progenitor lymphoid cells might be more prone to virus recognition than mature cells. Although the ability of mitogen-stimulated PBMC from infected woodchucks to produce infectious WHV has been shown previously (Korba et aL, 1988; Michalak et at., 1994b) , cells of spleen and bone marrow could be the main WHV target and the site of viral replication since these organs in adult mammals embrace the most active proliferative expansion of lymphoid cells.
